Schwann cell-conditioned medium inhibits angiogenesis.

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Neuroblastomas are heterogeneous tumors with neuroblastic/ganglionic and Schwann cells.
• Tumor prognosis correlates with Schwannian stroma content; stroma-rich tumors have favorable outcomes.
• Previous research linked high vascularity to aggressive neuroblastoma, while stroma-rich tumors showed low vascularity.

Purpose of the Study:

• To investigate if Schwann cells inhibit angiogenesis in neuroblastoma.
• To assess the effect of conditioned medium from Schwann cells on endothelial cell proliferation and migration.
• To examine in vivo and in vitro angiogenesis using conditioned medium from normal and tumor-derived Schwann cells.

Main Methods:

• Conditioned medium from normal human Schwann cells and tumor-derived Schwann cells was used.
• Endothelial cell proliferation and migration assays were performed.
• In vivo and in vitro angiogenesis assays were conducted.
• Expression studies, including immunohistochemistry, identified specific molecules.

Main Results:

• Schwann cells, from both normal nerve and tumor tissue, produce potent angiogenesis inhibitors.
• Tissue inhibitor of metalloproteinase-2 (TIMP-2) was detected in conditioned medium and within Schwann cells and ganglion cells in tumors.
• Tumors with abundant Schwannian stroma exhibited low vascularity.

Conclusions:

• Schwann cells likely inhibit angiogenesis in neuroblastoma.
• The production of TIMP-2 by Schwann cells may contribute to the low vascularity and favorable prognosis of stroma-rich neuroblastomas.
• Schwann cells play a significant role in regulating tumor microenvironment and behavior.